Key Points Kate Mitchell acquired 2,350 RAL shares on Feb. 10, 2026, for a transaction value of ~$100,000 at around $42.48 per share. All shares are held indirectly through The Wesley and Katherine Mitchell Living Trust, with no direct holdings reported after the transaction. After the transaction, Mitchell held 8,411 shares indirectly and 0 shares directly. 10 stocks we like better than Ralliant ...
Key Points Kate Mitchell acquired 2,350 RAL shares on Feb. 10, 2026, for a transaction value of ~$100,000 at around $42.48 per share. All shares are held indirectly through The Wesley and Katherine Mitchell Living Trust, with no direct holdings reported after the transaction. After the transaction, Mitchell held 8,411 shares indirectly and 0 shares directly. 10 stocks we like better than Ralliant › Kate Mitchell, Director of Ralliant (NYSE:RAL), reported an open-market purchase of 2,350 shares for a total consideration of ~$100,000, according to a SEC Form 4 filing dated Feb. 12, 2026. Transaction summary Metric Value Shares traded 2,350 Transaction value $99,828.00 Post-transaction shares (direct) 0 Post-transaction shares (indirect) 8,411 Transaction value based on SEC Form 4 reported price ($42.48). Key questions What was the structure and entity context of this transaction? All 2,350 shares were purchased indirectly through The Wesley and Katherine Mitchell Living Trust, where Mitchell serves as trustee and beneficiary, with no shares acquired or held directly. All 2,350 shares were purchased indirectly through The Wesley and Katherine Mitchell Living Trust, where Mitchell serves as trustee and beneficiary, with no shares acquired or held directly. How did this purchase impact Mitchell's overall ownership stake? The acquisition raised the trust's position by 38.77%, increasing indirect holdings from 6,061 to 8,411 shares, while direct ownership remains at zero. Company overview Metric Value Revenue (TTM) $2.07 billion Net Loss (TTM) $1.22 billion Dividend yield 0.20% Price (as of market close 3/21/26) $40.80 Company snapshot Ralliant provides advanced measurement and sensor technologies for defense and space applications. It designs and manufactures precision instruments, test and measurement systems, and specialty sensors. The company's strategy centers on innovation in precision measurement and sensor technology. What this transaction means for investors Ralli...
Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $2.36 million, reflecting both trading activity and price movements. After the trade, the fund held 476,826 shares valued at $15.61 million 10 stocks we like better than Axo...
Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $2.36 million, reflecting both trading activity and price movements. After the trade, the fund held 476,826 shares valued at $15.61 million 10 stocks we like better than Axogen › DAFNA Capital Management cut its holding in Axogen (NASDAQ:AXGN) by 265,456 shares in the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February 17, 2026, SEC filing. What happened According to a SEC filing dated February 17, 2026, DAFNA Capital Management reduced its position in Axogen (NASDAQ:AXGN) by 265,456 shares during the fourth quarter of 2025. The estimated transaction value of the sale is $6.53 million, calculated using the average closing price for the quarter. The fund finished the period with 476,826 shares of Axogen, worth $15.61 million at quarter end. What else to know After the sale, Axogen represents 3.63% of the fund's 13F reportable assets under management. Top holdings after the filing include: NASDAQ:RVMD: $48.15 million (11.33% of AUM) NYSEMKT:XBI: $41.03 million (9.65% of AUM) NYSEMKT:STXS: $31.47 million (7.40% of AUM) NASDAQ:ATRC: $23.63 million (5.56% of AUM) NASDAQ:CYTK: $23.57 million (5.55% of AUM) As of Friday, AXGN shares were priced at $30.78, up 71% over the past year and well outperforming the S&P 500, which is instead up about 15% in the same period. Company overview Metric Value Market Capitalization $1.6 billion Revenue (TTM) $225.2 million Net Income (TTM) ($15.7 million) Price (as of Friday) $30.78 Company Snapshot AxoGen develops and markets surgical solutions for peripheral nerve repair, including Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector, AxoGuard Nerve Cap, Avive Soft Tissue Membrane, and AxoTouch two-point discriminator. The firm generates re...
Key Points On March 25, 2026, The Vita Coco Company will join the S&P SmallCap 600, effective prior to the opening of the trading day. The company's stock has been performing strong in previous months, and it recently released a new flavor for one if its popular products. 10 stocks we like better than Vita Coco › Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), di...
Key Points On March 25, 2026, The Vita Coco Company will join the S&P SmallCap 600, effective prior to the opening of the trading day. The company's stock has been performing strong in previous months, and it recently released a new flavor for one if its popular products. 10 stocks we like better than Vita Coco › Corey Baker, Chief Financial Officer of The Vita Coco Company, Inc. (NASDAQ:COCO), disclosed the sale of 4,000 shares of common stock on March 17, 2026 and March 18, 2026, as detailed in the SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 4,000 Transaction value ~$236,000 Post-transaction shares (direct) 27,951 Post-transaction value (direct ownership) ~$1.56 million Transaction value based on SEC Form 4 weighted average purchase price ($58.98); post-transaction value based on March 18, 2026 market close ($52.88). Key questions What proportion of Baker's holding was impacted by this trade? The sale accounted for 12.52% of Baker's direct common stock holdings prior to the transaction. The sale accounted for 12.52% of Baker's direct common stock holdings prior to the transaction. What is the context of Baker’s transactions? The transactions were executed under a Rule 10b5-1 trading plan, allowing Baker to sell the shares in advance. Company overview Metric Value Revenue (TTM) $609.78 million Net income (TTM) $71.32 million Employees 319 1-year price change 50.44% * 1-year price change calculated as of March 21, 2026. Company snapshot The Vita Coco Company, Inc. develops and distributes coconut-based and functional hydration products, including coconut water, coconut oil, coconut milk, hydration drink mixes, sparkling water, plant-based energy drinks, purified water, and protein-infused fitness drinks. It targets health-conscious consumers in the United States, Canada, Europe, the Middle East, and the Asia Pacific, selling primarily through large retailers, convenience stores, and online platforms. What this transaction means for inves...
"If you are not happy about this government, then in 2027 [you can] just kick it off the bus, change to another government. Now, the matter of the referendum is what counts."
"If you are not happy about this government, then in 2027 [you can] just kick it off the bus, change to another government. Now, the matter of the referendum is what counts."
Key Points DAFNA Capital Management bought 720,000 shares of Biohaven in the fourth quarter; the estimated trade size was $8.92 million, based on average prices in the fourth quarter of 2025. Meanwhile, the quarter-end value of the position rose by $7.25 million, reflecting both the share increase and stock price changes during the period. Post-trade, the fund held 955,235 shares valued at $10.78 ...
Key Points DAFNA Capital Management bought 720,000 shares of Biohaven in the fourth quarter; the estimated trade size was $8.92 million, based on average prices in the fourth quarter of 2025. Meanwhile, the quarter-end value of the position rose by $7.25 million, reflecting both the share increase and stock price changes during the period. Post-trade, the fund held 955,235 shares valued at $10.78 million, accounting for 2.51% of AUM, which places it outside the fund's top five holdings. 10 stocks we like better than Biohaven › DAFNA Capital Management reported a buy of 720,000 shares of Biohaven (NYSE:BHVN) in a February 17, 2026, SEC filing, with the estimated transaction value at $8.92 million based on quarterly average pricing. What happened According to a February 17, 2026, SEC filing, DAFNA Capital Management increased its position in Biohaven by 720,000 shares during the fourth quarter of 2025. The estimated value of this trade was $8.92 million, based on quarterly average pricing. The stake’s total value at quarter-end was $10.78 million, up $7.25 million from the previous period, a change reflecting both the additional shares and movements in the stock’s price. What else to know DAFNA’s Biohaven position now represents 2.51% of its reportable U.S. equity assets after this buy. Top five holdings after the filing: NASDAQ:RVMD: $48.15 million (11.3% of AUM) NYSEMKT:XBI: $41.03 million (9.7% of AUM) NYSEMKT:STXS: $31.47 million (7.4% of AUM) NASDAQ:ATRC: $23.63 million (5.6% of AUM) NASDAQ:CYTK: $23.57 million (5.5% of AUM) As of Friday, Biohaven shares were priced at $8.93, down a staggering 68% over the past year and significantly underperforming the S&P 500, which is instead up about 15% in the same period. Company overview Metric Value Price (as of Friday) $8.93 Market Capitalization $1.3 billion Net Income (TTM) ($738.8 million) Company snapshot Biohaven develops clinical-stage therapies targeting neurological and immunoscience diseases, with no commerciali...
编程模型竞争加剧,模型厂商开发应用挤压应用公司 Cursor于3月19日发布新一代编程模型Composer-2,据称能以较低价格实现介于OpenAI GPT5.4(high)和Anthropic Claude Opus 4.6(high)的性能。图:IC photo 【财新网】 Cursor将模型研发确立为首要目标后,其新模型陷入侵权争议。针对新模型Composer-2是否由月之暗面Kimi K2...
编程模型竞争加剧,模型厂商开发应用挤压应用公司 Cursor于3月19日发布新一代编程模型Composer-2,据称能以较低价格实现介于OpenAI GPT5.4(high)和Anthropic Claude Opus 4.6(high)的性能。图:IC photo 【财新网】 Cursor将模型研发确立为首要目标后,其新模型陷入侵权争议。针对新模型Composer-2是否由月之暗面Kimi K2.5模型微调而来的广泛质疑,美国AI编程应用Cursor联合创始人、COO阿曼·桑格(Aman Sanger )于3月21日做出确认回应。 Cursor于3月19日发布新一代编程模型Composer-2,据称能以较低价格实现介于OpenAI GPT5.4(high)和Anthropic Claude Opus 4.6(high)的性能。但开发者在使用时发现,其代码中的模型ID为“Kimi-k2p5”,由此提出Composer-2就是带强化学习的K2.5。
President Donald Trump threatened to attack Iran’s power plants if the country didn’t swiftly open the Strait of Hormuz to commercial ship traffic that has paralyzed the passage of oil and gas cargoes. Trump said in a social media post on Saturday that he would “hit and obliterate” Iran’s power plants, beginning with the biggest one, if it didn’t open the strait within 48 hours. The comments from ...
President Donald Trump threatened to attack Iran’s power plants if the country didn’t swiftly open the Strait of Hormuz to commercial ship traffic that has paralyzed the passage of oil and gas cargoes. Trump said in a social media post on Saturday that he would “hit and obliterate” Iran’s power plants, beginning with the biggest one, if it didn’t open the strait within 48 hours. The comments from Trump, on his Truth Social media platform, marked a dramatic escalation in the US president’s rhetoric about the strait, just 24 hours after he said the responsibility for policing it would fall to the countries reliant on shipping through the corridor. Threats have nearly paralyzed the shipment of commodities through the Strait of Hormuz, which provides transit for roughly 20% of the world’s oil and gas. The resulting energy supply shock has sent crude prices soaring, with international benchmark Brent futures closing at $112.19 on Friday. The remarks mark a shift in tone since Trump on Friday said the US was considering “winding down” military efforts in the Persian Gulf. Trump previously had been pressuring allies to deploy forces to help the US secure the strait.
But the episode made headlines around the world - especially because Brixton Academy was the scene of a fatal crush in 2022, when a large crowd gathered outside the venue and tried to force their way in, resulting in two deaths.
But the episode made headlines around the world - especially because Brixton Academy was the scene of a fatal crush in 2022, when a large crowd gathered outside the venue and tried to force their way in, resulting in two deaths.
Julia had a plan: spring break, Kuala Lumpur’s skyline, then a long-overdue reunion in the jungles of Sarawak. What she got instead was a travel booking screen showing €3,000 (US$3,440) flights and a cascade of cancellation alerts. “I just can’t afford that,” the 22-year-old Romanian told This Week in Asia. Her original Emirates itinerary had her transiting through Dubai or Abu Dhabi, but the US-I...
Julia had a plan: spring break, Kuala Lumpur’s skyline, then a long-overdue reunion in the jungles of Sarawak. What she got instead was a travel booking screen showing €3,000 (US$3,440) flights and a cascade of cancellation alerts. “I just can’t afford that,” the 22-year-old Romanian told This Week in Asia. Her original Emirates itinerary had her transiting through Dubai or Abu Dhabi, but the US-Israel war on Iran upended her plans after the carrier warned of disruptions and two-week postponements as regional airspace closed, sending airfares skyrocketing. Advertisement Backup options on Turkish Airlines via Istanbul or KLM via Amsterdam were similarly expensive. Julia, who asked to be identified only by her first name, was left watching a reunion in Malaysia she had spent months planning slip out of reach. Her experience is the kind of private disruption now casting a shadow over Malaysia ’s most ambitious tourism push in years. People look at Kuala Lumpur’s skyline from an observation deck in Kuala Lumpur. Malaysia welcomed more than 42 million international visitors in 2025. Photo: Reuters After welcoming more than 42 million international visitors in 2025 – an 11.2 per cent increase from a year earlier – Visit Malaysia 2026 began with bullish official rhetoric and a campaign meant to showcase the country as one of Asia’s more affordable, easy-to-reach destinations.
DAFNA Capital Management reported selling 222,847 shares of Syndax Pharmaceuticals (NASDAQ:SNDX) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.89 million based on quarterly average pricing. According to an SEC filing dated February 17, 2026, DAFNA Capital Management reduced its position in Syndax Pharmaceuticals by 222,847 shares during the fourth quarter. The es...
DAFNA Capital Management reported selling 222,847 shares of Syndax Pharmaceuticals (NASDAQ:SNDX) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.89 million based on quarterly average pricing. According to an SEC filing dated February 17, 2026, DAFNA Capital Management reduced its position in Syndax Pharmaceuticals by 222,847 shares during the fourth quarter. The estimated value of the shares sold was approximately $3.89 million, based on the mean unadjusted closing price for the quarter. The value of the stake at quarter’s end declined by $1.87 million, reflecting both share sales and price movement. Syndax Pharmaceuticals, Inc. is a biotechnology company specializing in the development of novel therapies for cancer, with a focus on hematologic malignancies and immune-mediated conditions. The company leverages a pipeline of differentiated assets and strategic collaborations to advance its clinical programs. Syndax's approach centers on addressing unmet medical needs in oncology, positioning it as a key innovator within the biopharmaceutical sector. Continue reading
You may be surprised to learn that even with a war in Iran and a so-so economy, the S&P 500 is only down around 5% from its high. The reality is that there's a lot of strength in various sectors across the market, and most companies are doing just fine. However, there's one sector of the market that isn't doing as well as the others in 2026, and it may come as a surprise: artificial intelligence (...
You may be surprised to learn that even with a war in Iran and a so-so economy, the S&P 500 is only down around 5% from its high. The reality is that there's a lot of strength in various sectors across the market, and most companies are doing just fine. However, there's one sector of the market that isn't doing as well as the others in 2026, and it may come as a surprise: artificial intelligence (AI). Although AI gets a ton of publicity and a huge amount of spending, investors haven't shown these stocks nearly as much love as they did during the previous three years. This has caused many impressive AI stocks to sell off, which may be a huge warning sign about the sector as a whole. However, I think investors should get a different signal from this sell-off, and now is the time to act. AI stocks look like bargains While there isn't an AI index investors can point to, one common exchange-traded fund (ETF) I use to track general AI stock performance is the Global X Artificial Intelligence & Technology ETF. This ETF is down around 9% from its all-time high, so it has fallen considerably more than the S&P 500, but it's still not a level most would find concerning. If you peel back the layers a bit and look at some top investment options, you'll see several popular AI stocks down significantly from their highs. Among them are Nvidia (NVDA 3.17%), Microsoft (MSFT 1.92%), and Palantir Technologies (PLTR 3.29%). These three represent the leaders in three different areas of AI investing. Nvidia is a play on AI infrastructure, Palantir is an AI software company, and Microsoft is a cloud infrastructure and business integration investment. Expand NASDAQ : MSFT Microsoft Today's Change ( -1.92 %) $ -7.48 Current Price $ 381.54 Key Data Points Market Cap $2.8T Day's Range $ 380.12 - $ 386.79 52wk Range $ 344.79 - $ 555.45 Volume 1.7M Avg Vol 34M Gross Margin 68.59 % Dividend Yield 0.91 % Of these three, Nvidia is faring the best, but Microsoft and Palantir are each having a much w...
Kate Mitchell, Director of Ralliant (RAL 4.11%), reported an open-market purchase of 2,350 shares for a total consideration of ~$100,000, according to a SEC Form 4 filing dated Feb. 12, 2026. Transaction summary Metric Value Shares traded 2,350 Transaction value $99,828.00 Post-transaction shares (direct) 0 Post-transaction shares (indirect) 8,411 Transaction value based on SEC Form 4 reported pri...
Kate Mitchell, Director of Ralliant (RAL 4.11%), reported an open-market purchase of 2,350 shares for a total consideration of ~$100,000, according to a SEC Form 4 filing dated Feb. 12, 2026. Transaction summary Metric Value Shares traded 2,350 Transaction value $99,828.00 Post-transaction shares (direct) 0 Post-transaction shares (indirect) 8,411 Transaction value based on SEC Form 4 reported price ($42.48). Key questions What was the structure and entity context of this transaction? All 2,350 shares were purchased indirectly through The Wesley and Katherine Mitchell Living Trust, where Mitchell serves as trustee and beneficiary, with no shares acquired or held directly. All 2,350 shares were purchased indirectly through The Wesley and Katherine Mitchell Living Trust, where Mitchell serves as trustee and beneficiary, with no shares acquired or held directly. How did this purchase impact Mitchell's overall ownership stake? The acquisition raised the trust's position by 38.77%, increasing indirect holdings from 6,061 to 8,411 shares, while direct ownership remains at zero. Company overview Metric Value Revenue (TTM) $2.07 billion Net Loss (TTM) $1.22 billion Dividend yield 0.20% Price (as of market close 3/21/26) $40.80 Expand NYSE : RAL Ralliant Today's Change ( -4.11 %) $ -1.75 Current Price $ 40.80 Key Data Points Market Cap $4.6B Day's Range $ 40.46 - $ 42.57 52wk Range $ 37.27 - $ 57.02 Volume 2M Avg Vol 1.8M Gross Margin 46.08 % Dividend Yield 0.37 % Company snapshot Ralliant provides advanced measurement and sensor technologies for defense and space applications. It designs and manufactures precision instruments, test and measurement systems, and specialty sensors. The company's strategy centers on innovation in precision measurement and sensor technology. What this transaction means for investors Ralliant had a highly underwhelming Q4 FY 2025 earnings report on Feb. 4, 2026, reporting a $1.3 billion net loss, compared to $82.7 million in net income in the sam...